These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 1077780)
1. Dopa, catecholamines and their metabolites in essential hypertension. Januszewicz W; Wocial B Clin Sci Mol Med Suppl; 1975 Jun; 2():295s-298s. PubMed ID: 1077780 [TBL] [Abstract][Full Text] [Related]
2. Changes in the excretion of catecholamines and their metabolites in patients with essential hypertension during sodium intake restriction. Wocial B; Januszewicz W; Chodakowska J; Feltynowski T Cor Vasa; 1981; 23(3):222-8. PubMed ID: 6790225 [TBL] [Abstract][Full Text] [Related]
3. Dopamine and dopa urinary excretion in patients with pheochromocytoma--diagnostic implications. Januszewicz W; Wocial B; Januszewicz A; Gryglas P; Prejbisz A Blood Press; 2001; 10(4):212-6. PubMed ID: 11800059 [TBL] [Abstract][Full Text] [Related]
4. Catecholamines and their metabolites in the brain and urine of rats with experimental Parkinson's disease. Chekhonin VP; Baklaushev VP; Kogan BM; Savchenko EA; Lebedev SV; Man'kovskaya IV; Filatova TS; Yusupova IU; Dmitrieva TB Bull Exp Biol Med; 2000 Aug; 130(8):805-9. PubMed ID: 11177250 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the usefulness for measuring catecholamines and their principle metabolites in the diagnosis of pheochromocytoma]. Wocial B; Januszewicz W; Gryglas P; Januszewicz A; Feltynowski T; Lapiński M Przegl Lek; 1997; 54(11):793-8. PubMed ID: 9501691 [TBL] [Abstract][Full Text] [Related]
6. [Administration of the catecholamine precursor, L-DOPA, for evaluating their in vivo biosynthesis in hypertension]. Kiseleva ZM; Parfenova EV; Erina EV; Shkhvatsabaia IK Kardiologiia; 1979 Oct; 19(10):55-60. PubMed ID: 502171 [TBL] [Abstract][Full Text] [Related]
7. [Urinary excretion of catecholamines and sodium and potassium levels in serum and erythrocytes in patients with renal hypertension]. Midelauri BG Kardiologiia; 1967 Jul; 7(7):66-7. PubMed ID: 5607172 [No Abstract] [Full Text] [Related]
8. Plasma and urinary catecholamines and metabolites during physical exercise in essential hypertension. Chodakowska J; Wocial B; Skórka B; Nazar K; Chwalbińska-Moneta J Acta Physiol Pol; 1980; 31(6):623-30. PubMed ID: 6787836 [TBL] [Abstract][Full Text] [Related]
9. [L-DOPA test for evaluating in vivo catecholamine biosynthesis in normal persons and persons with different diseases]. Vasil'ev VN; Matlina ESh Vopr Med Khim; 1977; (3):332-8. PubMed ID: 888397 [TBL] [Abstract][Full Text] [Related]
10. [Catecholamine metabolism in different forms of Parkinson's disease]. Selikhova MV; Kogan BM; Serkin GV; Gusev EI Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):37-40. PubMed ID: 12378880 [TBL] [Abstract][Full Text] [Related]
11. Study of some biological indices of the state of the sympathoadrenaline system under the effect of polychlorocamphene. Kuz'minskaya UA; Ivanitskiĭ VA Environ Health Perspect; 1979 Jun; 30():91-5. PubMed ID: 446464 [TBL] [Abstract][Full Text] [Related]
12. Secretion of dopa in phaeochromocytoma. Louis WJ; Doyle AE; Heath WC; Robinson MJ Br Med J; 1972 Nov; 4(5836):325-7. PubMed ID: 4637512 [TBL] [Abstract][Full Text] [Related]
13. [Qualitative analysis of the main urinary metabolites of dopamine, epinephrine and norepinephrine by gas chromatography]. Bègue RJ; Bazerolle O; Desgres J; Lallemant C; Padieu P Pathol Biol (Paris); 1971; 19(15):719-25. PubMed ID: 4942503 [No Abstract] [Full Text] [Related]
14. Urinary excretion of catecholamines and their metabolites in patients with renovascular hypertension. Januszewicz W; Wocial B Jpn Heart J; 1978 Jul; 19(4):468-78. PubMed ID: 731871 [TBL] [Abstract][Full Text] [Related]
15. [The effect of guanethidine upon the diurnal rhythm of cathecholamines, dopa and dopamine in patients with hypertension]. Vishnepol'skiĭ IuIa Sov Med; 1969 Jan; 32(1):52-6. PubMed ID: 5385216 [No Abstract] [Full Text] [Related]
16. [Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients]. Vasil'ev VN Vopr Med Khim; 1980; 26(6):782-6. PubMed ID: 6779421 [TBL] [Abstract][Full Text] [Related]
17. An increase in urinary catecholamines of renal origin in patients with "borderline" hypertension. Kuchel O; Cuche JL; Buu NT; Genest J Am J Med Sci; 1976; 272(3):263-8. PubMed ID: 1015511 [TBL] [Abstract][Full Text] [Related]
18. Catecholamine turnover in normotensive and hypertensive man: effects of antiadrenergic drugs. DeQuattro V; Sjoerdsma A J Clin Invest; 1968 Oct; 47(10):2359-73. PubMed ID: 5676529 [TBL] [Abstract][Full Text] [Related]
19. [Catecholamine and DOPA excretion in peptic ulcer patients]. Frenkel' ID Vopr Med Khim; 1973; 19(5):518-23. PubMed ID: 4788178 [No Abstract] [Full Text] [Related]
20. [The effect of aminazine on the excretion of adrenaline noradrenaline, dopamine and dopa in healthy subjects and in the manic phase of manic-depressive psychosis]. Matlina ESh; Osipova MS Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(1):128-31. PubMed ID: 5448719 [No Abstract] [Full Text] [Related] [Next] [New Search]